“As a preliminary matter, the GMC invites us to adopt the approach adopted to appeals under section 40 of the 1983 Act, to appeals under section 40A of the 1983 Act, and we consider it is right to do so. It follows that the well-settled principles developed in relation to section 40 appeals (in cases including: Meadow v General Medical Council[2006] EWCA Civ 1390 ;[2007] QB 462 ; Fatnani and Raschid v General Medical Council[2007] EWCA Civ 46 ;[2007] 1 WLR 1460 ; and Southall v General Medical Council[2010] EWCA Civ 407 ;[2010] 2 FLR 1550 ) as appropriately modified, can be applied to section 40A appeals. In summary: i) Proceedings under section 40A of the 1983 Act are appeals and are governed byCPR Part 52 . A court will allow an appeal underCPR Part 52.21 (3) if it is 'wrong' or 'unjust because of a serious procedural or other irregularity in the proceedings in the lower court'. ii) It is not appropriate to add any qualification to the test inCPR Part 52 that decisions are 'clearly wrong': see Fatnani at paragraph 21 and Meadow at paragraphs 125 to 128. iii) The court will correct material errors of fact and of law: see Fatnani at paragraph 20. Any appeal court must however be extremely cautious about upsetting a conclusion of primary fact, particularly where the findings depend upon the assessment of the credibility of the witnesses, who the Tribunal, unlike the appellate court, has had the advantage of seeing and hearing (see Assicurazioni Generali SpA v Arab Insurance Group (Practice Note)[2002] EWCA Civ 1642 ;[2003] 1 WLR 577 , at paragraphs 15 to 17, cited with approval in Datec Electronics Holdings Ltd v United Parcels Service Ltd[2007] UKHL 23 ,[2007] 1 WLR 1325 at paragraph 46, and Southall at paragraph 47). iv) When the question is what inferences are to be drawn from specific facts, an appellate court is under less of a disadvantage. The court may draw any inferences of fact which it considers are justified on the evidence: seeCPR Part 52.11 (4). v) In regulatory proceedings the appellate court will not have the professional expertise of the Tribunal of fact. As a consequence, the appellate court will approach Tribunal determinations about whether conduct is serious misconduct or impairs a person's fitness to practise, and what is necessary to maintain public confidence and proper standards in the profession and sanctions, with diffidence: see Fatnani at paragraph 16; and Khan v General Pharmaceutical Council[2016] UKSC 64 ;[2017] 1 WLR 169 , at paragraph 36. vi) However there may be matters, such as dishonesty or sexual misconduct, where the court "is likely to feel that it can assess what is needed to protect the public or maintain the reputation of the profession more easily for itself and thus attach less weight to the expertise of the Tribunal …": see Council for the Regulation of Healthcare Professionals v GMC and Southall[2005] EWHC 579 (Admin) ; [2005] Lloyd's Rep. Med 365 at paragraph 11, and Khan at paragraph 36(c). As Lord Millett observed in Ghosh v GMC[2001] UKPC 29 ;[2001] 1 WLR 1915 and 1923G, the appellate court "will afford an appropriate measure of respect of the judgment in the committee … but the [appellate court] will not defer to the committee's judgment more than is warranted by the circumstances". vii) Matters of mitigation are likely to be of considerably less significance in regulatory proceedings than to a court imposing retributive justice, because the overarching concern of the professional regulator is the protection of the public. viii) A failure to provide adequate reasons may constitute a serious procedural irregularity which renders the Tribunal's decision unjust (see Southall at paragraphs 55 to 56).”
“61 The decision of the Tribunal that suspension rather than erasure was an appropriate sanction for the failings of Professor Bawa-Garba, which led to her conviction for gross negligence manslaughter, was an evaluative decision based on many factors, a type of decision sometimes referred to as "a multi-factorial decision". This type of decision, a mixture of fact and law, has been described as "a kind of jury question" about which reasonable people may reasonably disagree … . It has been repeatedly stated in cases at the highest level that there is limited scope for an appellate court to overturn such a decision. … 63 … In the recent case of R (Bowen and Stanton) v Secretary of State for Justice[2017] EWCA Civ 2181 , McCombe LJ explained (at [65]) that, when the appeal is from a trial judge's multi-factorial decision, "the appeal court's approach will be conditioned by the extent to which the first instance judge had an advantage over the appeal court in reaching his/her decision. If such an advantage exists, then the appeal court will be more reticent in differing from the trial judge's evaluations and conclusions". … 67 That general caution applies with particular force in the case of a specialist adjudicative body, such as the Tribunal in the present case, which (depending on the matter in issue) usually has greater experience in the field in which it operates than the courts: see Smech at [30]; Khan v General Pharmaceutical Council[2016] UKSC 64 ,[2017] 1 WLR 169 at [36]; Meadow at [197]; and Raschid v General Medical Council[2007] EWCA Civ 46 ,[2007] 1 WLR 1460 at [18]-[20]. An appeal court should only interfere with such an evaluative decision if (1) there was an error of principle in carrying out the evaluation, or (2) for any other reason, the evaluation was wrong, that is to say it was an evaluative decision which fell outside the bounds of what the adjudicative body could properly and reasonably decide … … 94 As we said earlier in this judgment, the Tribunal was, in relation to all those matters and the carrying out of an evaluative judgement as to the appropriate sanction for maintaining public confidence in the profession, an expert panel, familiar with this type of adjudication and comprising a medical practitioner and two lay members, one of whom was legally qualified, all of whom were assisted by a legal assessor.”
“Between2 May 2017 and16 November 2017 while employed as a full-time Professor of General Practice at Warwick Medical School, University of Warwick (“the University”) you also undertook paid private work for …”
“He was due thereafter to commence his employment shortly afterwards in, as I understand it, mid-January 2017, though he actually started working for the medical school on2 May 2017 , as you will see from Graham Partridge’s statement in due course. No application was submitted between those periods – certainly the first part of 2017 – by Professor Walton regarding that ongoing paid work externally, either at Summertown or Queen Mary. Moving things forward in terms of the material you have in the bundle to6 October 2017 , Professor Walton was invited to a meeting with Professor Frances Griffiths, the Head of Division of Health Service at the University, and Simon Crick, the Chief Finance Officer. Professor Griffiths is being called by the GMC in this case as a witness and she will say that she had become concerned in the months leading up to that meeting as to how many teaching and clinical PAs Professor Walton was performing. Professor Griffiths sent an email to Professor Walton following that meeting on 6 October – page 66 – to confirm what she understood had been discussed in that regard: that is, that Professor Walton was conducting two PAs on his programme grant, seven PAs on research activity, and was building towards, as it is put, two PAs of teaching. When you clock those up that left him one PA short of the 12 that he was contracted for, and it was confirmed it seems that no clinical work was being conducted by him at all for the university. You will see at paragraph 2 of the email, page 66: “In addition to the 11 PAs above you are working a day a week as a GP in the practice that you worked at prior to moving to WMS. [Warwick] The practice is paying you for one session a week.”
“You informed me that you agreed with Sudhesh [Professor Kumar] that this one session could be paid directly to you.”
“Subsequent to our meeting I had the opportunity to mention our meeting to Sudhesh. Sudhesh is not aware of you having formally applied to do the external work (the one clinical session a week that is paid to you by your practice). There is a process for gaining University approval for this. Please could you confirm you have done this. If you have not done this then you need to apply urgently.”
“Subsequent to our meeting I had the opportunity to mention our meeting to Sudhesh. Sudhesh is not aware of you having formally applied to do the external work (the one clinical session a week that is paid to you by your practice). There is a process for gaining University approval for this. Please could you confirm you have done this. If you have not done this then you need to apply urgently.”
“It is an application you need to make under ‘private outside work’ where you would state it would not interfere with your academic duties. If you applied I can’t think of a reason for me to object so you can expect it will be approved. However see the point below, it is the very essence of what we are creating – a joined up clinical academic post and this would fall outside those arrangements. Also you should be aware that this would not obviate the need to provide input to the Coventry Health Centre …”
“Q The impression you had from the previous conversation that you had been given the green light is being corrected, isn't it? A He also then goes on to say – I didn’t know what he meant by the first sentence of this, “It is an application that you need to make under ‘private outside work’.”
“6. The decisions from this court have demonstrated that a very strict line has been taken in relation to findings of dishonesty. This court and its predecessor, the Privy Council, has repeatedly recognised that for all professional men and women, a finding of dishonesty lies at the top end of the spectrum of gravity of misconduct; see Tait v Royal College of Veterinary Surgeons[2003] UKPC 34 at paragraph 13. … 8. In cases of proven dishonesty, the balance can be expected to fall down on the side of maintaining public confidence in the profession by a severe sanction against the doctor concerned. See Nicholas-Pillai v GMC[2009] EWHC 1048 (Admin) per Mitting J at [27] where he stated: “That sanction will often and perfectly properly be the sanction of erasure, even in the case of a one-off instance of dishonesty.” 9. Where proven dishonesty is combined with a lack of insight (or is covered up) the authorities show that nothing short of erasure is likely to be appropriate.” “That sanction will often and perfectly properly be the sanction of erasure, even in the case of a one-off instance of dishonesty.”
“Any of the following factors being present may indicate erasure is appropriate (this list is not exhaustive): a A particularly serious departure from the principles set out in Good medical practice where the behaviour is fundamentally incompatible with being a doctor. b A deliberate or reckless disregard for the principles set out in Good medical practice and/or patient safety. … h Dishonesty, especially where persistent and/or covered up (see guidance below at paragraphs 120–128). j Persistent lack of insight into the seriousness of their actions or the consequences.”
“Dishonesty, if persistent and/or covered up, is likely to result in erasure (see further guidance at paragraph 120-128).”
“16. The Tribunal considered that Prof Walton’s dishonesty was serious and constituted a breach of a fundamental tenet of the profession, namely acting with honesty and integrity. The public must have confidence that doctors will at all times act with honesty. Prof Walton did not do this. 17. The Tribunal took into account that Prof Walton repeatedly asserted that he would behave differently if faced with similar situations in the future. The Tribunal had no reason to doubt Prof Walton’s apparent insight into his own personal shortcomings in terms of administration. However, this does not explain his conduct in relation to the findings of dishonesty and he has continued to deny that he acted dishonestly. It considered that, though possible, dishonest conduct is difficult to remediate. Given his denial of dishonesty, at present there is no evidence before the Tribunal to indicate that Prof Walton has reflected on, or taken steps to remedy, his misconduct. Indeed, Prof Walton has not asserted that he has undertaken any remediation. In those circumstances, the Tribunal could not be satisfied that there is no risk of repetition of his dishonest conduct.”
“11. The Tribunal carefully considered and balanced the aggravating and mitigating factors in Prof Walton’s case. 12. The Tribunal noted that Prof Walton has an otherwise unblemished record, his dishonest conduct took place over one and a half years ago and there has since been no repetition. Prof Walton has fully engaged with the GMC investigation and with this hearing. There is an extensive amount of overwhelmingly positive testimonial evidence which attest to Prof Walton’s otherwise good character. The evidence suggests that Prof Walton is a highly skilled academic and clinician who is eminent in his field. The misconduct took place in the context of an environment in which Prof Walton’s line management appeared to be unstructured and it was unclear what was covered in his induction. 13. However, the Tribunal has already found that Prof Walton’s conduct was a clear departure from a number of principles of GMP, and that acting dishonestly is a serious matter which undermines the trust in the medical profession. Prof Walton was dishonest on two occasions, albeit in relation to common circumstances, namely his external earnings from private outside work. Prof Walton benefitted financially from his dishonest actions. The Tribunal has already found that, given his denial of dishonesty, there is no evidence before the Tribunal to indicate that Prof Walton has reflected on, or taken steps to remedy, his misconduct. … Suspension … 20. The Tribunal took into account that Prof Walton was dishonest on more than one occasion, so his misconduct cannot be described as isolated. However, it noted the instances of his dishonesty were in relation to common circumstances, namely his external earnings from private outside work. It was not persuaded that the dishonesty was persistent such that it necessitated or warranted erasure from the Medical Register. 21. In its previous determination, the Tribunal stated that it could not be satisfied that there is no risk of repetition of his dishonest conduct. It took into careful consideration the testimonials provided on Prof Walton’s behalf. It was of the view that these provided a wealth of good quality evidence of Prof Walton’s otherwise good character, the majority of the authors of the testimonials being aware of the allegations. The testimonial evidence satisfied the Tribunal that Prof Walton’s dishonest conduct was wholly out of character. It was of the view that, based on the evidence, it would be likely that Prof Walton would revert back to his usual good character should similar circumstances arise in the future. As such, it was satisfied that the risk of repetition was minimal. 22. Having had regard to the circumstances of this case, the Tribunal was satisfied that Prof Walton’s misconduct is not fundamentally incompatible with continued registration. It was of the view that erasing Prof Walton’s name from the Medical Register would be disproportionate, punitive and not in the public interest. 23. The Tribunal determined that a period of suspension would be an appropriate and proportionate sanction that would protect the public confidence in the medical profession and promote and maintain proper standards and conduct for the members of the profession. At the same time, a period of suspension would also mark the gravity with which the Tribunal viewed such misconduct.”